임주영 (한국생명공학연구원)님 | 한빛사연구자 > 한빛사

한국생명공학연구원

최종업데이트 2026.02.11.

Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition
- J. Adv. Res., Available online 10 February 2026 | https://doi.org/10.1016/j.jare.2026.02.012
- 2026-02
- 의약학
- 한빛사논문
CYB5R3 functions as a tumor suppressor by inducing ER stress-mediated apoptosis in lung cancer cells via the PERK-ATF4 and IRE1α-JNK pathways
- Exp. Mol. Med., Jan 22 2024, | https://doi.org/10.1038/s12276-024-01155-9
- 2024-01
- 생명과학
- 한빛사논문
- 임주영(University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 현 한국생명공학연구원)
DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway
- Hum. Mol. Genet., 2012 Jul 1;21(13):3013-24 | https://doi.org/10.1093/hmg/dds131
- 2012-07
- 생명과학
- 상위피인용논문
DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer
- Exp. Mol. Med., 2023 May 1 | https://doi.org/10.1038/s12276-023-00974-6
- 2023-05
- 생명과학
- 한빛사논문

연구자 ID

저자논문